Which has better valuation & earnings, LFMD or DCGO?

LifeMD has higher earnings, but lower revenue than DocGo. LifeMD is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LifeMD $194.05M 0.77 $14.35M -$0.05 N/A DocGo $322.20M 0.12 -$182.40M -$1.96 N/A

Is LFMD or DCGO more profitable?

LifeMD has a net margin of 0.10% compared to DocGo's net margin of -65.29%. DocGo's return on equity of -40.42% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 0.10% -168.23% -31.27% DocGo -65.29% -40.42% -24.81%

Do analysts rate DCGO or JYNT?

DocGo currently has a consensus target price of $2.38, suggesting a potential upside of 489.77%. Given DocGo's stronger consensus rating and higher probable upside, analysts clearly believe DocGo is more favorable than Joint. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33 Joint 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, DCGO or JYNT?

Joint has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio DocGo $322.20M 0.12 -$182.40M -$1.96 N/A Joint $54.90M 2.14 $2.91M $0.27 30.81

Is DCGO or JYNT more profitable?

Joint has a net margin of 6.49% compared to DocGo's net margin of -65.29%. Joint's return on equity of 12.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets DocGo -65.29% -40.42% -24.81% Joint 6.49% 12.02% 3.47%

Does the media refer more to DCGO or JYNT?

In the previous week, Joint had 1 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Joint and 1 mentions for DocGo. Joint's average media sentiment score of 0.34 beat DocGo's score of 0.00 indicating that Joint is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Joint 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is ACH or DCGO more profitable?

Accendra Health has a net margin of -11.41% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets Accendra Health -11.41% -4.02% 0.70% DocGo -65.29% -40.42% -24.81%

Does the media prefer ACH or DCGO?

In the previous week, Accendra Health and Accendra Health both had 1 articles in the media. Accendra Health's average media sentiment score of 1.73 beat DocGo's score of 0.00 indicating that Accendra Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Accendra Health 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, PIII or DCGO?

P3 Health Partners has higher revenue and earnings than DocGo. P3 Health Partners is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio P3 Health Partners $1.46B 0.05 -$147.95M -$33.00 N/A DocGo $322.20M 0.12 -$182.40M -$1.96 N/A

Is PIII or DCGO more profitable?

P3 Health Partners has a net margin of -6.55% compared to DocGo's net margin of -65.29%. P3 Health Partners' return on equity of 0.00% beat DocGo's return on equity. Company Net Margins Return on Equity Return on Assets P3 Health Partners -6.55% N/A -16.40% DocGo -65.29% -40.42% -24.81%

Does the media refer more to PIII or DCGO?

In the previous week, P3 Health Partners and P3 Health Partners both had 1 articles in the media. P3 Health Partners' average media sentiment score of 0.00 equaled DocGo'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment P3 Health Partners 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

DocGo (DCGO) Competitors

$0.40 0.00 (-0.52%)

As of 09/4/2026 04:00 PM Eastern

Compare

DCGO vs. LFMD, JYNT, PARK, ACH, and PIII

Should you buy DocGo stock or one of its competitors? DocGo's main competitors and comparable companies include LifeMD (LFMD), Joint (JYNT), Park Dental Partners (PARK), Accendra Health (ACH), and P3 Health Partners (PIII). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does DocGo compare to LifeMD?

LifeMD (NASDAQ:LFMD) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.

In the previous week, DocGo had 1 more articles in the media than LifeMD. MarketBeat recorded 1 mentions for DocGo and 0 mentions for LifeMD. LifeMD's average media sentiment score of 0.00 equaled DocGo'saverage media sentiment score.

Company	Overall Sentiment
LifeMD	Neutral
DocGo	Neutral

35.5% of LifeMD shares are owned by institutional investors. Comparatively, 56.4% of DocGo shares are owned by institutional investors. 17.2% of LifeMD shares are owned by company insiders. Comparatively, 5.1% of DocGo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

LifeMD presently has a consensus price target of $7.57, suggesting a potential upside of 145.83%. DocGo has a consensus price target of $2.38, suggesting a potential upside of 489.77%. Given DocGo's higher probable upside, analysts clearly believe DocGo is more favorable than LifeMD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

LifeMD has a beta of 2.04, indicating that its stock price is 104% more volatile than the broader market. Comparatively, DocGo has a beta of 0.94, indicating that its stock price is 6% less volatile than the broader market.

LifeMD has a net margin of 0.10% compared to DocGo's net margin of -65.29%. DocGo's return on equity of -40.42% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	0.10%	-168.23%	-31.27%
DocGo	-65.29%	-40.42%	-24.81%

LifeMD has higher earnings, but lower revenue than DocGo. LifeMD is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	0.77	$14.35M	-$0.05	N/A
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A

Summary

LifeMD beats DocGo on 8 of the 15 factors compared between the two stocks.

How does DocGo compare to Joint?

DocGo (NASDAQ:DCGO) and Joint (NASDAQ:JYNT) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership and profitability.

56.4% of DocGo shares are held by institutional investors. Comparatively, 76.9% of Joint shares are held by institutional investors. 5.1% of DocGo shares are held by insiders. Comparatively, 30.2% of Joint shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Joint has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Joint, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A
Joint	$54.90M	2.14	$2.91M	$0.27	30.81

In the previous week, Joint had 1 more articles in the media than DocGo. MarketBeat recorded 2 mentions for Joint and 1 mentions for DocGo. Joint's average media sentiment score of 0.34 beat DocGo's score of 0.00 indicating that Joint is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Joint	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

DocGo has a beta of 0.94, suggesting that its share price is 6% less volatile than the broader market. Comparatively, Joint has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

Joint has a net margin of 6.49% compared to DocGo's net margin of -65.29%. Joint's return on equity of 12.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Joint	6.49%	12.02%	3.47%

DocGo currently has a consensus target price of $2.38, suggesting a potential upside of 489.77%. Given DocGo's stronger consensus rating and higher probable upside, analysts clearly believe DocGo is more favorable than Joint.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Joint	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Joint beats DocGo on 12 of the 16 factors compared between the two stocks.

How does DocGo compare to Park Dental Partners?

DocGo (NASDAQ:DCGO) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

In the previous week, DocGo had 1 more articles in the media than Park Dental Partners. MarketBeat recorded 1 mentions for DocGo and 0 mentions for Park Dental Partners. DocGo's average media sentiment score of 0.00 equaled Park Dental Partners'average media sentiment score.

Company	Overall Sentiment
DocGo	Neutral
Park Dental Partners	Neutral

Park Dental Partners has lower revenue, but higher earnings than DocGo. DocGo is trading at a lower price-to-earnings ratio than Park Dental Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A
Park Dental Partners	$244.49M	0.40	-$360K	$1.05	19.46

DocGo currently has a consensus price target of $2.38, indicating a potential upside of 489.77%. Park Dental Partners has a consensus price target of $28.50, indicating a potential upside of 39.50%. Given DocGo's higher probable upside, research analysts plainly believe DocGo is more favorable than Park Dental Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Park Dental Partners	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Park Dental Partners has a net margin of 0.00% compared to DocGo's net margin of -65.29%. Park Dental Partners' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	-65.29%	-40.42%	-24.81%
Park Dental Partners	N/A	N/A	N/A

56.4% of DocGo shares are owned by institutional investors. 5.1% of DocGo shares are owned by insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Park Dental Partners beats DocGo on 10 of the 15 factors compared between the two stocks.

How does DocGo compare to Accendra Health?

Accendra Health (NYSE:ACH) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability.

56.4% of DocGo shares are held by institutional investors. 2.3% of Accendra Health shares are held by company insiders. Comparatively, 5.1% of DocGo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Accendra Health has a net margin of -11.41% compared to DocGo's net margin of -65.29%. Accendra Health's return on equity of -4.02% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Accendra Health	-11.41%	-4.02%	0.70%
DocGo	-65.29%	-40.42%	-24.81%

DocGo has lower revenue, but higher earnings than Accendra Health. Accendra Health is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accendra Health	$2.65B	0.04	-$1.10B	-$3.91	N/A
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A

In the previous week, Accendra Health and Accendra Health both had 1 articles in the media. Accendra Health's average media sentiment score of 1.73 beat DocGo's score of 0.00 indicating that Accendra Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Accendra Health	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Accendra Health has a beta of 1.53, suggesting that its stock price is 53% more volatile than the broader market. Comparatively, DocGo has a beta of 0.94, suggesting that its stock price is 6% less volatile than the broader market.

Accendra Health currently has a consensus target price of $1.50, indicating a potential upside of 23.46%. DocGo has a consensus target price of $2.38, indicating a potential upside of 489.77%. Given DocGo's stronger consensus rating and higher possible upside, analysts plainly believe DocGo is more favorable than Accendra Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accendra Health	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

DocGo beats Accendra Health on 9 of the 15 factors compared between the two stocks.

How does DocGo compare to P3 Health Partners?

P3 Health Partners (NASDAQ:PIII) and DocGo (NASDAQ:DCGO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk and institutional ownership.

7.8% of P3 Health Partners shares are held by institutional investors. Comparatively, 56.4% of DocGo shares are held by institutional investors. 10.9% of P3 Health Partners shares are held by insiders. Comparatively, 5.1% of DocGo shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

P3 Health Partners has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market. Comparatively, DocGo has a beta of 0.94, meaning that its stock price is 6% less volatile than the broader market.

P3 Health Partners has higher revenue and earnings than DocGo. P3 Health Partners is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
P3 Health Partners	$1.46B	0.05	-$147.95M	-$33.00	N/A
DocGo	$322.20M	0.12	-$182.40M	-$1.96	N/A

P3 Health Partners presently has a consensus target price of $17.00, suggesting a potential upside of 81.82%. DocGo has a consensus target price of $2.38, suggesting a potential upside of 489.77%. Given DocGo's stronger consensus rating and higher possible upside, analysts clearly believe DocGo is more favorable than P3 Health Partners.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
P3 Health Partners	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
DocGo	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

P3 Health Partners has a net margin of -6.55% compared to DocGo's net margin of -65.29%. P3 Health Partners' return on equity of 0.00% beat DocGo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
P3 Health Partners	-6.55%	N/A	-16.40%
DocGo	-65.29%	-40.42%	-24.81%

In the previous week, P3 Health Partners and P3 Health Partners both had 1 articles in the media. P3 Health Partners' average media sentiment score of 0.00 equaled DocGo'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
P3 Health Partners	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DocGo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

P3 Health Partners and DocGo tied by winning 7 of the 14 factors compared between the two stocks.

Get DocGo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DCGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DCGO vs. The Competition

Export

Metric	DocGo	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$39.84M	$10.00B	$7.25B	$12.92B
Dividend Yield	N/A	2.59%	2.53%	9.14%
P/E Ratio	-0.21	29.17	213.35	20.98
Price / Sales	0.12	4.97	625.09	95.03
Price / Cash	7.28	121.42	77.08	52.44
Price / Book	0.42	3.99	12.85	6.17
Net Income	-$182.40M	$313.25M	$3.49B	$350.08M
7 Day Performance	1.31%	1.06%	1.04%	-0.14%
1 Month Performance	-35.86%	0.33%	5.52%	1.02%
1 Year Performance	-74.51%	15.31%	24.39%	14.51%

DocGo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DCGO DocGo	2.8848 of 5 stars	$0.40 -0.5%	$2.38 +489.8%	-73.3%	$39.84M	$322.20M	N/A	3,568
LFMD LifeMD	2.9829 of 5 stars	$3.14 -3.7%	$7.57 +141.1%	-51.0%	$151.35M	$194.05M	N/A	230
JYNT Joint	2.2957 of 5 stars	$8.43 +0.2%	N/A	-22.0%	$119.20M	$54.90M	31.22	320	News Coverage Analyst Upgrade
PARK Park Dental Partners	3.4311 of 5 stars	$20.85 -4.3%	$28.50 +36.7%	N/A	$99.25M	$244.49M	19.86	1,212	Positive News Analyst Upgrade
ACH Accendra Health	2.2022 of 5 stars	$1.23 +1.2%	$1.50 +22.4%	N/A	$94.20M	$2.73B	N/A	6,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DCGO) was last updated on 9/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

DocGo (DCGO) Competitors

DCGO vs. LFMD, JYNT, PARK, ACH, and PIII

How does DocGo compare to LifeMD?

Summary

How does DocGo compare to Joint?

Summary

How does DocGo compare to Park Dental Partners?

Summary

How does DocGo compare to Accendra Health?

Summary

How does DocGo compare to P3 Health Partners?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCGO vs. The Competition

DocGo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

DocGo (DCGO) Competitors

DCGO vs. LFMD, JYNT, PARK, ACH, and PIII

How does DocGo compare to LifeMD?

Does the media refer more to LFMD or DCGO?

Do institutionals and insiders hold more shares of LFMD or DCGO?

Do analysts prefer LFMD or DCGO?

Which has more volatility and risk, LFMD or DCGO?

Is LFMD or DCGO more profitable?

Which has better valuation & earnings, LFMD or DCGO?

Summary

How does DocGo compare to Joint?

Do institutionals & insiders have more ownership in DCGO or JYNT?

Which has better earnings & valuation, DCGO or JYNT?

Does the media refer more to DCGO or JYNT?

Which has more risk and volatility, DCGO or JYNT?

Is DCGO or JYNT more profitable?

Do analysts rate DCGO or JYNT?

Summary

How does DocGo compare to Park Dental Partners?

Does the media favor DCGO or PARK?

Which has stronger earnings & valuation, DCGO or PARK?

Do analysts recommend DCGO or PARK?

Is DCGO or PARK more profitable?

Do institutionals and insiders have more ownership in DCGO or PARK?

Summary

How does DocGo compare to Accendra Health?

Do insiders and institutionals believe in ACH or DCGO?

Is ACH or DCGO more profitable?

Which has better valuation and earnings, ACH or DCGO?

Does the media prefer ACH or DCGO?

Which has more volatility and risk, ACH or DCGO?

Do analysts prefer ACH or DCGO?

Summary

How does DocGo compare to P3 Health Partners?

Do institutionals and insiders have more ownership in PIII or DCGO?

Which has more risk and volatility, PIII or DCGO?

Which has stronger earnings and valuation, PIII or DCGO?

Do analysts prefer PIII or DCGO?

Is PIII or DCGO more profitable?

Does the media refer more to PIII or DCGO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DCGO vs. The Competition

DocGo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools